About
The scientific poster titled “Participant Feasibility: Direct Engagement with Patients to Impact MASH Trial Design and Site Selection” evaluates data from ProSciento’s Patient Access & Engagement (PAE) platform, presented at this year’s NASH Paris Meeting. The poster evaluates the data from pre-study participant feasibility campaigns for 12 metabolic dysfunction-associated steatohepatitis (MASH) study protocols utilizing a database of 29,879 individuals with comorbidities related to the prevalence of MASH/MASLD. The resulting insights held significant value in demonstrating study feasibility, identifying participation barriers, aiding in site selection decisions, enhancing patient enrollment and retention, and ultimately improving overall efficiency.
